Archean Chemical Industries Intrinsic Value
ACI • Chemicals
Current Stock Price
₹583.90
Primary Intrinsic Value
₹175.17
Market Cap
₹1460 Cr
-31.8%
Downside
Median Value
₹397.95
Value Range
₹175 - ₹746
Assessment
Trading Above Calculated Value
Safety Margin
-46.7%
ACI Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹175.17 | ₹140.14 - ₹210.20 | -70.0% | EPS: ₹9.44, Sector P/E: 12x |
| Book Value Method | asset | ₹745.60 | ₹671.04 - ₹820.16 | +27.7% | Book Value/Share: ₹745.60, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹307.20 | ₹276.48 - ₹337.92 | -47.4% | Revenue/Share: ₹384.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹662.40 | ₹596.16 - ₹728.64 | +13.4% | EBITDA: ₹276.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹653.58 | ₹522.86 - ₹784.30 | +11.9% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹175.17 | ₹157.65 - ₹192.69 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹175.17 | ₹157.65 - ₹192.69 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹464.00 | ₹417.60 - ₹510.40 | -20.5% | ROE: 6.2%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹397.95 | ₹358.15 - ₹437.75 | -31.8% | EPS: ₹9.44, BVPS: ₹745.60 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
ACI Intrinsic Value Analysis
What is the intrinsic value of ACI?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Archean Chemical Industries (ACI) is ₹397.95 (median value). With the current market price of ₹583.90, this represents a -31.8% variance from our estimated fair value.
The valuation range spans from ₹175.17 to ₹745.60, indicating ₹175.17 - ₹745.60.
Is ACI undervalued or overvalued?
Based on our multi-method analysis, Archean Chemical Industries (ACI) appears to be trading above calculated value by approximately 31.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.08 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 6.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.40x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Archean Chemical Industries
Additional stock information and data for ACI
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹176 Cr | ₹53 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹379 Cr | ₹226 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹496 Cr | ₹351 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹315 Cr | ₹260 Cr | Positive Free Cash Flow | 8/10 |